208 related articles for article (PubMed ID: 30251745)
21. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
22. Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
Minardi D; Milanese G; Parri G; Lacetera V; Muzzonigro G
Arch Ital Urol Androl; 2016 Mar; 88(1):13-6. PubMed ID: 27072170
[TBL] [Abstract][Full Text] [Related]
23. Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
Brant A; Kates M; Chappidi MR; Patel HD; Sopko NA; Netto GJ; Baras AS; Hahn NM; Pierorazio PM; Bivalacqua TJ
Urol Oncol; 2017 Jan; 35(1):34.e17-34.e25. PubMed ID: 27639777
[TBL] [Abstract][Full Text] [Related]
24. "Complete transurethral resection of bladder tumor": are the guidelines being followed?
Adiyat KT; Katkoori D; Soloway CT; De los Santos R; Manoharan M; Soloway MS
Urology; 2010 Feb; 75(2):365-7. PubMed ID: 19963238
[TBL] [Abstract][Full Text] [Related]
25. Management of high-risk non-muscle invasive bladder cancer.
Brausi M; Olaru V
Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
[TBL] [Abstract][Full Text] [Related]
26. Differences in Pathologic Results of Repeat Transurethral Resection of Bladder Tumor (TURBT) according to Institution Performing the Initial TURBT: Comparative Analyses between Referred and Nonreferred Group.
Yuk HD; Kim JK; Jeong CW; Kwak C; Kim HH; Ku JH
Biomed Res Int; 2018; 2018():9432606. PubMed ID: 30271788
[TBL] [Abstract][Full Text] [Related]
27. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
[TBL] [Abstract][Full Text] [Related]
30. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
[TBL] [Abstract][Full Text] [Related]
31. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
32. Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?
Alsyouf M; Ladi-Seyedian SS; Konety B; Pohar K; Holzbeierlein JM; Kates M; Willard B; Taylor JM; Liao JC; Kaimakliotis HZ; Porten SP; Steinberg GD; Tyson MD; Lotan Y; Daneshmand S;
Urol Oncol; 2023 Feb; 41(2):109.e9-109.e14. PubMed ID: 36435710
[TBL] [Abstract][Full Text] [Related]
33. Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving bacillus Calmette-Guérin.
Angulo JC; Palou J; García-Tello A; de Fata FR; Rodríguez O; Villavicencio H
Actas Urol Esp; 2014 Apr; 38(3):164-71. PubMed ID: 24613147
[TBL] [Abstract][Full Text] [Related]
34. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
35. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
[TBL] [Abstract][Full Text] [Related]
36. High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional Study.
Ferro M; Vartolomei MD; Cantiello F; Lucarelli G; Di Stasi SM; Hurle R; Guazzoni G; Busetto GM; De Berardinis E; Damiano R; Perdonà S; Borghesi M; Schiavina R; Almeida GL; Bove P; Lima E; Grimaldi G; Autorino R; Crisan N; Abu Farhan AR; Verze P; Battaglia M; Serretta V; Russo GI; Morgia G; Musi G; de Cobelli O; Mirone V; Shariat SF
Urol Int; 2018; 101(1):7-15. PubMed ID: 29975950
[TBL] [Abstract][Full Text] [Related]
37. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
Richterstetter M; Wullich B; Amann K; Haeberle L; Engehausen DG; Goebell PJ; Krause FS
BJU Int; 2012 Jul; 110(2 Pt 2):E76-9. PubMed ID: 22313727
[TBL] [Abstract][Full Text] [Related]
38. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Ge P; Wang ZC; Yu X; Lin J; He Q
BMC Urol; 2015 May; 15():46. PubMed ID: 26025446
[TBL] [Abstract][Full Text] [Related]
40. Relook TURBT in superficial bladder cancer: its importance and its correlation with the tumor ploidy.
Dwivedi US; Kumar A; Das SK; Trivedi S; Kumar M; Sunder S; Singh PB
Urol Oncol; 2009; 27(5):514-9. PubMed ID: 18639472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
